Things you need to know about Vyleesi - the new treatment for sexual desire disorder in women12/25/2020 VYLEESI is a medicine prescribed by the doctors for the treatment of hypoactive sexual desire disorder (HSDD) in females who haven't yet gone through menopause, had no problems with low sexual desire previously, or who experience low sexual desire despite the type of sexual activity, the state, or the sexual companion. Women having HSDD experience a decreased sexual desire which can be quite troubling to them. Their diminished sexual desire is not because of:
Vyleesi should not be mistaken as Female Viagra However some media platforms state Vyleesi is the female variant of Viagra, but the new drug works in entirely different behavior from that pill. Viagra or sildenafil works as a sexual performance medicine, whereas Vyleesi treatment is recognized as a sexual desire treatment. Viagra operates on the functioning of sex by expanding the blood vessels providing blood circulation to the penis. But the system by which Vylessi operates is not very clear, it is considered to modify the ways that add to sex drive and libodo. It’s also essential to regard that female HSDD remains a remarkably complicated condition that’s identified by a loss of libido, caused by various factors. How is Vyleesi different? Vyleesi is the only second medicine licensed for the treatment of HSDD. It comes in the form of an injection that females can take at home in the abdomen or thigh at least an hour before expected sexual activity. The additional medication used for HSDD is Addyi (flibanserin), which was given FDA approval in 2015. This medicine is administered every day in the form of a pill to increase sex drive. Vyleesi is used as an as-needed drug, but Addyi is to be taken every day. There are also several non pharmacological options to try to improve libido. Clinical evidence Vyleesi was examined in a couple of huge randomized clinical trials before FDA approval, including 1,247 premenopausal women. The efficacy of the drug was ascertained by scores of sexual desire, which were given by the members. Outcomes revealed that nearly 25% of females that received Vyleesi treatment experienced an elevation of 1.2 or greater in their score associated with about 17% who received a placebo.
0 Comments
Leave a Reply. |
AuthorAs a trusted compounding pharmacy in California, Harbor Compounding Pharmacy has one goal: to provide personalized, effective solutions to your medication problems. Our ultimate mission is to fill the gap in healthcare with high-quality, well-studied, and efficacious formulations aimed at improving overall health and quality of life. Archives
January 2024
Categories |